Title: Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance (Replace Cysto)
- Principal Investigator: Dr. Lewis Thomas
- Study Coordinators: Carley Browning
This is a multi-site randomized phase 2 trial including 240 patients with early- stage bladder cancer, in which patients will be randomized 1:1:1 to programmatic surveillance with the Xpert bladder cancer urine test, the Bladder EpiCheck urine test, or frequent cystoscopy. The primary outcome will be urinary quality of life 1 to 3 days after surveillance
This study is administered by VREF and funded by the NCI (National Cancer Institute).
Find Out More
This study is currently enrolling participants. To learn more about Replace Cysto and how you can join contact our research office at (314) 289-7690.
If you are a veteran receiving care through the VA St. Louis Health Care System and believe you may be eligible for this study, please speak with your Physician. For general information about our research, please visit our main Clinical Trials page or contact us directly.